(S (NP-SBJ (NN Interferon) (NN alpha)) (ADVP (RB selectively)) (VP (VBZ affects) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (JJ human) (JJ myeloid) (NN cell) (JJ nuclear) (NN differentiation) (NN antigen))) (PP (IN in) (NP (NP (JJ late) (NN stage) (NNS cells)) (PP (IN in) (NP (NP-COOD (NP (DT the) (JJ monocytic) (NP (-NONE- *RNR*-12))) (CONJP (CC but) (RB not)) (NP (DT the) (JJ granulocytic) (NP (-NONE- *RNR*-12)))) (NP-12 (NN lineage)))))))) (. .))
(S (NP-SBJ-13 (DT The) (JJ human) (NP (NP (JJ myeloid) (NN cell) (JJ nuclear) (NN differentiation) (NN antigen)) (PRN (-LRB- -LRB-) (NP (NN MNDA)) (-RRB- -RRB-)))) (VP (VBZ is) (VP (VBN expressed) (NP-14 (-NONE- *-13)) (ADVP (RB constitutively)) (PP (IN in) (NP (NP (NNS cells)) (PP (IN of) (NP (DT the) (JJ myeloid) (NN lineage))))) (, ,) (S (NP-SBJ-15 (-NONE- *-14)) (VP-COOD (VP (VBG appearing) (PP (IN in) (NP (NP (JJ myeloblast) (NNS cells)) (PP (IN in) (NP (NP (DT some) (NNS cases)) (PP (IN of) (NP (JJ acute) (JJ myeloid) (NN leukemia)))))))) (CC and) (VP (ADVP-TMP (RB consistently)) (VBG being) (VP (VBN detected) (NP (-NONE- *-15)) (PP-COOD (PP (IN in) (NP (JJ promyelocyte) (NN stage) (NNS cells))) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (NP (DT all) (JJR later) (NN stage) (NNS cells)) (PP (VBG including) (NP-COOD (NP (JJ peripheral) (NN blood) (NNS monocytes)) (CC and) (NP (NNS granulocytes))))))))))))) (. .))
(S (NP-SBJ (NP (DT The) (JJ human) (JJ myeloid) (NN leukemia) (NN cell) (NNS lines)) (, ,) (NP-COOD (NP (NN HL-60)) (, ,) (NP (NN U937)) (, ,) (CC and) (NP (NN THP-1))) (, ,)) (VP (VBP express) (NP (NP (JJ similar) (NNS levels)) (PP (IN of) (NP (ADJP (RB immunochemically) (JJ detectable)) (NN MNDA))))) (. .))
(S (SBAR (IN Although) (, ,) (S (NP-SBJ (NP (DT the) (NN level)) (PP (IN of) (NP (NN MNDA) (NN mRNA))) (PP (IN in) (NP (JJ primary) (NNS monocytes)))) (VP (VBZ is) (ADJP-PRD (RB very) (JJ low))))) (NP-SBJ-16 (PRP it)) (VP (VBD was) (VP (VBN up-regulated) (NP (-NONE- *-16)) (PP-TMP (IN at) (NP (NP (CD 6) (NN h)) (PP-TMP (VBG following) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN interferon) (NN alpha))))))))) (. .))
(S (NP-SBJ-17 (NP (DT The) (NN effect)) (PP (IN of) (NP (NN interferon) (NN alpha))) (PP (IN on) (NP (DT the) (NN MNDA) (NN mRNA)))) (VP (VBZ is) (VP (ADVP (RB also)) (VBN observed) (NP (-NONE- *-17)) (PP (IN in) (NP (DT the) (NN cell) (NNS lines) (NP-COOD (NP (NN HL-60)) (, ,) (NP (NN U937)) (, ,) (CC and) (NP (NN THP-1))))))) (. .))
(S (NP-SBJ-18 (NP (DT The) (NN MNDA) (NN mRNA) (NN level)) (PP (IN in) (NP (JJ primary) (NNS granulocytes)))) (VP (VBD was) (VP (JJ unaffected) (NP (-NONE- *-18)) (PP (IN by) (NP-LGS (NP (NN addition)) (PP (IN of) (NP-COOD (NP (NN interferon) (NN alpha)) (CC and) (NP (NP (JJ other) (NNS agents)) (PP (VBG including) (NP-COOD (NP (NN interferon) (NN gamma)) (, ,) (NP (NN endotoxin)) (, ,) (NP (NN poly-LRB-I-RRB-.poly-LRB-C-RRB-)) (, ,) (CC and) (NP (NN FMLP))))))))))) (. .))
(S (NP-SBJ-19 (NP (DT The) (NN MNDA) (NN mRNA) (NN level)) (PP (IN in) (NP (DT the) (JJ myeloid) (NN cell) (NNS lines)))) (VP (VBD was) (VP (ADVP (RB also)) (JJ unaffected) (NP (-NONE- *-19)) (PP (IN by) (NP-LGS (DT the) (JJ latter) (CD four) (NNS agents))))) (. .))
(S (NP-SBJ (NP (NN Induction)) (PP (IN of) (NP (NN differentiation))) (PP (IN in) (NP (DT the) (JJ myeloid) (NN cell) (NNS lines))) (PP (IN with) (NP (NN phorbol) (NN ester)))) (VP (VBZ induces) (NP (NP (NN monocyte) (NN differentiation)) (SBAR (WHNP-20 (WDT which)) (S (NP-SBJ-21 (-NONE- *T*-20)) (VP (VBD was) (VP (VBN accompanied) (NP (-NONE- *-21)) (PP (IN by) (NP-LGS (NP (DT a) (NN decrease)) (PP (IN in) (NP (NN MNDA) (NN mRNA) (NN level))))))))))) (. .))
(S (NP-SBJ-22 (NP (DT This) (JJ reduced) (NN level)) (PP (IN of) (NP (NN mRNA)))) (VP (MD could) (ADVP-TMP (RB then)) (VP (VB be) (VP (JJ elevated) (NP (-NONE- *-22)) (PP (IN with) (NP (JJ subsequent) (NN interferon) (NN alpha) (NN treatment)))))) (. .))
(S (NP-SBJ-23 (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN phorbol) (NN ester))) (PP (IN on) (NP (NN MNDA) (NN mRNA)))) (VP (VBD appeared) (S (NP-SBJ-24 (-NONE- *-23)) (VP (TO to) (VP (VB be) (VP (VBN associated) (NP (-NONE- *-24)) (PP (IN with) (NP (VBN induced) (NN differentiation))))))) (SBAR (IN since) (S-COOD (S (S-SBJ (NP-SBJ (-NONE- *)) (VP (VBG inhibiting) (NP (NN cell) (NN proliferation)))) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN MNDA) (NN mRNA))))))) (CC and) (S (NP-SBJ-25 (NP (NN cell) (NN cycle) (NN variation)) (PP (IN in) (NP (NN MNDA) (NN mRNA) (NNS levels)))) (VP (VBD were) (RB not) (VP (VBN observed) (NP (-NONE- *-25)))))))) (. .))
(S (NP-SBJ (NP (DT The) (NN ability) (S (-NONE- *ICH*-26))) (PP (IN of) (NP (NN interferon) (NN alpha))) (S-26 (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB up-regulate) (NP (NN MNDA) (NN mRNA)) (PP (IN in) (NP (ADJP (NP (NN phorbol) (NN ester)) (JJ treated)) (JJ myeloid) (NN cell) (NNS lines))))))) (VP (VBZ is) (ADJP-PRD (JJ consistent) (PP (IN with) (NP (NP (DT the) (NNS observations)) (VP (VBN made) (NP (-NONE- *)) (PP (IN in) (NP (JJ primary) (NNS monocytes)))))))) (. .))
(S (-LRB- -LRB-) (NP-SBJ-100 (NN ABSTRACT)) (VP (VBN TRUNCATED) (NP (-NONE- *-100)) (PP (IN AT) (NP (CD 250) (NNS WORDS)))) (-RRB- -RRB-))
